Placebo News and Research

RSS

Gut microbes linked to severity of intestinal parasitic worm infections

A new study indicates that the kinds of microbes living in the gut influence the severity and recurrence of parasitic worm infections in developing countries.

9 Mar 2018

Gastrointestinal hormone offers possible new treatment for NAFLD and NASH patients

Through a randomized, double-blind, placebo-controlled phase II clinical trial, researchers at University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

9 Mar 2018

Study reveals new strategy to prevent mother-to-child transmission of hepatitis B virus

A clinical study coordinated by the French National Research Institute for Sustainable Development and Chiang Mai University with their Thai, American, and French partners, strengthens the case for a new strategy to prevent mother-to-child transmission of the hepatitis B virus.

8 Mar 2018

Jury’s in: Opioids are not better than other medicines for chronic pain

A few years ago, Renea Molden’s doctors told her they wanted to take her off her opioid pills. It did not sound like good idea to her.

6 Mar 2018

Study: Omega-3 fish oil supplements do not improve reading ability or memory function of kids

New research has found no evidence Omega-3 fish oil supplements help aid or improve the reading ability or memory function of underperforming school-children.

2 Mar 2018

Omega fatty acid supplements may improve ASD symptoms in toddlers born preterm, study shows

Researchers from Nationwide Children's Hospital have shown that omega fatty acid supplements may improve autism spectrum disorder symptoms in toddlers who were born very preterm (more than 11 weeks early). The study was published recently in the Journal of Nutrition.

1 Mar 2018

Optimism may help improve outcomes for patients with chronic angina

When it comes to coping with chronic angin a -- chest pain or pressure that comes on when the heart isn't getting enough oxygen, usually during physical activity -- a positive outlook may help improve outcomes over time, according to a study being presented at the American College of Cardiology's 67th Annual Scientific Session.

1 Mar 2018

Diabetes drug use during pregnancy may increase risk of obesity or overweight in children

When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity or overweight.

28 Feb 2018

Oxytocin nasal spray strengthens mothers' brain responses to pictures of infant and adult faces

In a new study from the University of Tampere in Finland, nasally administered oxytocin spray strengthened brain responses to pictures of infant and adult faces in mothers of 1-year-old infants.

26 Feb 2018

U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is supporting U.S. clinical sites participating in two ongoing international Phase 2 clinical trials evaluating investigational antibody-based therapies aimed at preventing potentially antibiotic-resistant infections.

23 Feb 2018

Beetroot may reduce kidney failure risk after heart x-ray, research reveals

Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.

22 Feb 2018

Prophylactic use of haloperidol does not reduce delirium burden

Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.

21 Feb 2018

Clinical trial shows safety of promising TSRI stroke drug

A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps Research Institute.

20 Feb 2018

Gout medication may help improve heart function in adult patients

Researchers at the University of Cincinnati College of Medicine have shown that probenecid, a drug long used to treat gout, may be able to improve heart function in adult patients who experience heart failure.

20 Feb 2018

Clinical trial studying type 1 diabetes reaches full enrollment

A clinical trial studying type 1 diabetes has reached full enrollment. The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., has completed enrollment of 110 children with type 1 diabetes. The study started with two sites at Sanford Health in Sioux Falls, South Dakota, and Fargo, North Dakota, and expanded to 13 additional sites across the United States.

19 Feb 2018

Psoriasis drug also effective at reducing aortic inflammation

Ustekinumab, sold under the name Stelara, is approved by the U.S. Food and Drug Administration to treat psoriasis, psoriatic arthritis, and Crohn's Disease. Researchers wanted to know if the benefits of the drug go beyond clearing the skin.

18 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

Common ketone supplement may reduce blood sugar in diabetics, suggests study

Consumption of a ketone supplement lowers blood sugar levels and may therefore help diabetics to control spikes in blood sugar, suggests a new study.

14 Feb 2018

MRI scans reveal why people often become aggressive after drinking alcohol

Researchers have used magnetic resonance imaging scans that measure blood flow in the brain to better understand why people often become aggressive and violent after drinking alcohol.

12 Feb 2018